AAP
Aristotle Atlantic Partners’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-199,445
| Closed | -$13.4M | – | 92 |
|
|
2024
Q3 | $13.4M | Buy |
199,445
+191
| +0.1% | +$12.8K | 0.42% | 53 |
|
|
2024
Q2 | $22.6M | Sell |
199,254
-1,208
| -0.6% | -$137K | 0.73% | 37 |
|
|
2024
Q1 | $27.8M | Sell |
200,462
-2,692
| -1% | -$373K | 0.91% | 33 |
|
|
2023
Q4 | $25.2M | Buy |
203,154
+2,323
| +1% | +$288K | 0.89% | 38 |
|
|
2023
Q3 | $18.7M | Sell |
200,831
-1,443
| -0.7% | -$135K | 0.75% | 45 |
|
|
2023
Q2 | $26M | Buy |
202,274
+36,544
| +22% | +$4.7M | 0.98% | 35 |
|
|
2023
Q1 | $19.3M | Buy |
165,730
+50
| +0% | +$5.81K | 0.99% | 38 |
|
|
2022
Q4 | $18.8M | Sell |
165,680
-17
| -0% | -$1.93K | 1.05% | 33 |
|
|
2022
Q3 | $13.3M | Buy |
165,697
+1,277
| +0.8% | +$103K | 0.81% | 44 |
|
|
2022
Q2 | $12.3M | Buy |
164,420
+124,044
| +307% | +$9.24M | 0.94% | 30 |
|
|
2022
Q1 | $20.7M | Buy |
40,376
+160
| +0.4% | +$81.9K | 1.28% | 27 |
|
|
2021
Q4 | $21.6M | Buy |
40,216
+194
| +0.5% | +$104K | 1.25% | 26 |
|
|
2021
Q3 | $21.9M | Buy |
40,022
+319
| +0.8% | +$174K | 1.45% | 28 |
|
|
2021
Q2 | $17M | Buy |
39,703
+39
| +0.1% | +$16.7K | 1.12% | 30 |
|
|
2021
Q1 | $14.3M | Buy |
39,664
+38
| +0.1% | +$13.7K | 1.04% | 33 |
|
|
2020
Q4 | $14.7M | Buy |
39,626
+924
| +2% | +$342K | 1.13% | 33 |
|
|
2020
Q3 | $16M | Buy |
38,702
+36
| +0.1% | +$14.8K | 1.41% | 27 |
|
|
2020
Q2 | $15.7M | Buy |
38,666
+10,124
| +35% | +$4.1M | 1.51% | 26 |
|
|
2020
Q1 | $7.69M | Buy |
+28,542
| New | +$7.69M | 1.17% | 30 |
|